Experimental cancer treatments are more beneficial than previously thought.
Recent study: Approximately 11%-and in some cases, 27%-of the patients in Phase 1 cancer trials responded positively. Previous reviews showed that only 4%to 6% benefited.
Want to Keep Reading?
Continue reading with a Health Confidential membership.
Sign up now
Already have an account? Sign in
You’ve successfully subscribed to Health Confidential
Welcome back! You’ve successfully signed in.
Great! You’ve successfully signed up.
Your link has expired
Success! Check your email for magic link to sign-in.